Cargando…

A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma

Recent randomized trials focused on gene expression-based determination of the cell of origin in diffuse large B-cell lymphoma could not show significant improvements by adding novel agents to standard chemoimmunotherapy. The aim of this study was the identification of a gene signature able to refin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Derenzini, Enrico, Mazzara, Saveria, Melle, Federica, Motta, Giovanna, Fabbri, Marco, Bruna, Riccardo, Agostinelli, Claudio, Cesano, Alessandra, Corsini, Chiara Antonia, Chen, Ning, Righi, Simona, Sabattini, Elena, Chiappella, Annalisa, Calleri, Angelica, Fiori, Stefano, Tabanelli, Valentina, Cabras, Antonello, Pruneri, Giancarlo, Vitolo, Umberto, Gianni, Alessandro Massimo, Rambaldi, Alessandro, Corradini, Paolo, Zinzani, Pier Luigi, Tarella, Corrado, Pileri, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409021/ https://www.ncbi.nlm.nih.gov/pubmed/32817282 http://dx.doi.org/10.3324/haematol.2019.236455

Ejemplares similares

The identification of TCF1(+) progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
por: Tabanelli, Valentina, et al.
Publicado: (2022)

Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
por: Rossi, Alessandra, et al.
Publicado: (2021)

Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment
por: Pileri, Stefano A., et al.
Publicado: (2021)

Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
por: Sapienza, Maria Rosaria, et al.
Publicado: (2019)

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
por: Pileri, Stefano A., et al.
Publicado: (2021)

Plasmablastic lymphoma: one or more tumors?
por: Pileri, Stefano A., et al.
Publicado: (2021)

Dissecting diffuse large B-cell lymphomas of the “not otherwise specified” type: the impact of molecular techniques
por: Pileri, Stefano A, et al.
Publicado: (2018)

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
por: Mazzara, Saveria, et al.
Publicado: (2022)

Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
por: Laginestra, Maria Antonella, et al.
Publicado: (2019)

Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
por: Laginestra, Maria Antonella, et al.
Publicado: (2019)

Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature
por: Tabanelli, Valentina, et al.
Publicado: (2011)

Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Sapienza, Maria Rosaria, et al.
Publicado: (2021)

NR1H3 (LXRα) is associated with pro‐inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b‐cell lymphoma
por: Vegliante, Maria Carmela, et al.
Publicado: (2022)

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue
por: Ciavarella, S, et al.
Publicado: (2018)

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue
por: Ciavarella, S, et al.
Publicado: (2019)

TOSCA: an automated Tumor Only Somatic CAlling workflow for somatic mutation detection without matched normal samples
por: Del Corvo, Marcello, et al.
Publicado: (2022)

TOX Expression in Mycosis Fungoides and Sezary Syndrome
por: Pileri, Alessandro, et al.
Publicado: (2022)

Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
por: Derenzini, Enrico, et al.
Publicado: (2015)

Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme
por: ZHAO, ZHAOHUI, et al.
Publicado: (2014)

A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies
por: Carpen, Laura, et al.
Publicado: (2022)

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi
por: Ballotta, Laura, et al.
Publicado: (2021)

Pathobiology of ALK-negative anaplastic large cell lymphoma
por: Pileri, Stefano A., et al.
Publicado: (2011)

Prognostic Markers in Peripheral T-Cell Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2010)

Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2010)

Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term
por: Cortelazzo, Sergio, et al.
Publicado: (2021)

Pathobiology of Hodgkin Lymphoma
por: Agostinelli, Claudio, et al.
Publicado: (2014)

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients
por: Pellegrini, Cinzia, et al.
Publicado: (2016)

Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma
por: Derenzini, Enrico, et al.
Publicado: (2015)

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres
por: Patanè, Monica, et al.
Publicado: (2013)

Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?
por: Chiappella, Annalisa, et al.
Publicado: (2019)

HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases
por: Fiori, Stefano, et al.
Publicado: (2021)

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
por: Sapienza, Maria Rosaria, et al.
Publicado: (2019)

Common Polymorphisms in the NFKBIA Gene and Cancer Susceptibility: A Meta-Analysis
por: Zhang, Meng, et al.
Publicado: (2015)

Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies
por: Agostinelli, C, et al.
Publicado: (2008)

Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified
por: Laginestra, M A, et al.
Publicado: (2014)

GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers
por: Hartmann, Sylvia, et al.
Publicado: (2012)

Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)

Genetic Association Between NFKBIA -881A>G Polymorphism and Cancer Susceptibility
por: Geng, Peiliang, et al.
Publicado: (2015)

Disseminated Mycobacterium malmoense and Salmonella Infections Associated with a Novel Variant in NFKBIA
por: Staples, Emily, et al.
Publicado: (2017)

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features
por: Cheng, Chao-Wen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gkf3ha2c4kcq38u75jloedds87